Ticker AEZS – Aeterna Zentaris – sales, description, marketcap – Tickerday.com

AEZS

Aeterna Zentaris

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 22.04M; Volume: 381.15K; AvgVol 3m: 5.43M; Beta: 1.58;

Cost estimate:

P/E: –; EPS: -0.18; EPS growth quarter/prev quarter: ;

EPS growth this year: -240.50%; EPS growth past 5 years: 58.80%;

EPS ttm: -0.18;

P/S: 14.80; P/B: 9.00; P/Cashflow: 3.31; P/FCF: ;

Sales: 1.46M; Sales growth quarter/prev quarter: -50.00%; Sales growth past 5 years: 117.20%;

Profitability:

Gross Margin: 18.90%; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -20.30%; ROE – return on equity: 786.70%; LT Debt/Equity: 0.11; Total Debt/Equity: 0.22;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.60%; Insider Transactions:0.00%;

Institutional Ownership: 21.40%; Institutional Transactions: 1.70%;

Data update: 07.10.2020.